Answers are grounded in this paper and cite their sources.
Tissue factor (TF) plays an essential role in hemostasis. The tissue-specific pattern of TF expression is consistent with additional hemostatic protection in vital organs. An aberrant expression of TF within the vasculature occurs in a variety of diseases, including atherosclerosis, cancer, and sepsis. TF expression in these diseases is associated with thrombotic events. Future therapeutic strategies may prove beneficial in the treatment of thrombosis. However, these strategies should be designed to avoid compromising hemostasis.
No takes yet. Share an insight, caveat, or question.
Tilley et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: